Resumen
Pharmaceutical combination for the treatment of gliomas. The present invention relates to a combination of drugs and cannabinoids for the treatment of a glioma that includes an antiangiogenic agent, a DNA alkylating compound and the mixture of two cannabinoid compounds. Specifically, it relates to a composition that includes bevacizumab (BVZ), temozolomide (TMZ) and a mixture of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD). (Machine-translation by Google Translate, not legally binding)